INOVIO PHARMACEUTICALS 1 RSS Feed | Nachrichten - www.finanzen.net

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO

Thu, 08 Jan 2026 16:00:00 +0100

NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ...

FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

Mon, 29 Dec 2025 14:05:00 +0100

PLYMOUTH MEETING, Pa., Dec. 29, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused ...

INOVIO Reports Inducement Grant Under Inducement Plan

Fri, 19 Dec 2025 22:05:00 +0100

PLYMOUTH MEETING, Pa., Dec. 19, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused ...

INOVIO to Participate in December Investor Conferences

Tue, 18 Nov 2025 14:05:00 +0100

PLYMOUTH MEETING, Pa., Nov. 18, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused ...

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Mon, 10 Nov 2025 22:05:00 +0100

Completed rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review
Expect to receive file acceptance ...

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Mon, 03 Nov 2025 14:05:00 +0100

Recurrent respiratory papillomatosis (RRP) is a rare HPV-related disease of the respiratory tract with significant unmet need
INO-3107 previously received Orphan Drug and Breakthrough ...

INOVIO Reports Inducement Grant Under Inducement Plan

Fri, 31 Oct 2025 21:53:00 +0100

PLYMOUTH MEETING, Pa., Oct. 31, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused ...

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

Mon, 27 Oct 2025 13:05:00 +0100

PLYMOUTH MEETING, Pa., Oct. 27, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused ...

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

Thu, 23 Oct 2025 22:05:00 +0200

PLYMOUTH MEETING, Pa., Oct. 23, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused ...

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

Tue, 21 Oct 2025 14:05:00 +0200

Publication includes complete data for all participants (n=39) up to week 72, further demonstrating durable and tolerable expression of DMAbs
Effective target binding ...